Literature DB >> 20542209

In vitro synergistic/additive activity of levofloxacin with meropenem against Stenotrophomonas maltophilia.

George A Pankey1, Deborah S Ashcraft.   

Abstract

Synergy testing of levofloxacin and meropenem by Etest and time-kill assay (TKA) was performed against 30 genetically unique clinical Stenotrophomonas maltophilia isolates. Synergy was demonstrated in 18/30 (60%) isolates by Etest and in 13/30 (43%) by TKA; the remaining isolates were indifferent. Methods showed agreement for 25/30 (83%) of isolates.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20542209     DOI: 10.1016/j.diagmicrobio.2010.02.015

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  1 in total

1.  Combination antimicrobial susceptibility testing of multidrug-resistant Stenotrophomonas maltophilia from cystic fibrosis patients.

Authors:  K E N Milne; I M Gould
Journal:  Antimicrob Agents Chemother       Date:  2012-05-14       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.